Plevitrexed

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePlevitrexed
Drug Alias Name普来曲塞plevitrexedumVamidexZD-9331BGC-9331
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsAbdominal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca PlcBtg Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsAbdominal Neoplasms

Other Information

ATC CodeN/A
Related LinksKEGG